CERo Therapeutics Statements
CE
Data from CERo Therapeutics`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency :
USD - US dollar
Last reporting period :
31 Dec, 2023
New report :
—
Reporting period :
Quarterly
Earnings release date:
—
Expected release date:
—
CERo Therapeutics Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
—
0
0.369
0
0.369
-14.1 %
0
-0.369
14.1 %
0
0.111
0
—
0
-0.258
16.2 %
0
0.024
0
-0.283
15.3 %
0
-0.04
6.529
—
—
100
—
0
—
—
0
—
0
0.43
0
0.43
-72.2 %
0
-0.43
72.2 %
0
0.121
0
—
0
-0.308
77.9 %
0
0.026
0
-0.334
76.8 %
0
-0.05
6.332
—
—
100
—
0
—
—
0
—
0
1.544
0
1.544
161.5 %
0
-1.544
-161.5 %
0
0.15
0
—
0
-1.393
-189.2 %
0
0.045
0
-1.438
-198.5 %
0
-0.21
6.77
—
—
100
—
0
—
—
0
—
0
0.59
0
0.59
-54.1 %
0
-0.59
54.1 %
0
0.109
0
—
0
-0.482
-274.5 %
0
—
0
-0.482
-83.4 %
0
-0.07
6.77
—
—
100
—
0
—
—
0
—
0
1.287
0
1.287
53.9 %
0
-1.287
-53.9 %
0
1.563
0
—
0
0.276
90.3 %
0
0.539
0
-0.263
-410.9 %
0
-0.01
21.027
—
—
100
—
0
—
—
0
—
0
0.837
0
0.837
122.2 %
0
-0.837
-122.2 %
0
0.982
0
—
0
0.145
229.9 %
0
0.06
0
0.085
175.7 %
0
—
22.981
—
—
100
—
0
—
—
0
—
0
0.377
0
0.377
-7 %
0
-0.377
7 %
0
0.265
0
—
0
-0.112
70.5 %
0
—
0
-0.112
70.5 %
0
—
22.981
—
—
100
—
0
—
—
0
—
0
0.405
0
0.405
22.3 %
0
-0.405
-22.3 %
0
0.027
0
—
0
-0.378
-14.1 %
0
—
0
-0.378
-20.2 %
0
-0.02
22.981
—
—
100
—
0
—
—
0
—
0
0.332
0
0.331
Infinity %
0
-0.331
-Infinity %
0
0
0
—
0
-0.331
-Infinity %
0
-0.017
0
-0.315
-Infinity %
0
-0.01
22.981
—
—
100
—
0
—
—
0
—
0
—
0
—
—
0
—
—
0
—
0
—
0
—
—
0
—
0
—
—
0
—
22.981